Close

Merck To Present Innovative Products for Displays at the FPD International in Makuhari (Japan)

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Eli Lilly’s $3.5 Billion Manufacturing Campus Advances in Upper Macungie, Pennsylvania

A planned $3.5 billion pharmaceutical manufacturing campus in Upper...

Overcoming Resistance-Associated Substitutions (RASs) to Direct-Acting Antivirals

Alt tag: Scientific illustration of Hepatitis C virus interacting...

Genentech Completes Structural Framework at New NC Manufacturing Facility

Genentech raised the final beam of its new Holly...
- Advertisement -

Merck KGaA announced today that it will be exhibiting at the FPD International, one of the leading events for the flat panel display industry, from November 10 to 12, 2010 in Makuhari / Chiba, (Japan). The global pharmaceutical and chemical company will be highlighting its innovative products for the display, lighting and photovoltaics segments.

Within its liquid crystal product range, Merck is going to present PS-VA (PS-VA = Polymer-Stabilized-Vertical-Alignment), a novel premium technology that offers better contrast, greater brightness, faster switching speed and makes it possible to reduce power consumption in LCD televisions. The colors appear more intense, warmer, and more natural. In addition, the spatial depth of the display is greater and movements are more lively. Also the newest screen-generation – 3D displays – will profit from this Merck technology. Merck’s PS-VA materials are a part of the innovative licristal® portfolio, which is based on a combination of a liquid crystals mixture with specially designed reactive mesogens resulting from a sophisticated production process.

Merck will also be providing information on its liquid crystal materials for ultra-fast switchable Blue Phase devices, which is seen as a future technology for extremely rapid picture motion, high contrast ratio and wide viewing angle. Cost-effective production is predicted due to the cell layout without alignment layers and less critical cell gap control.

 

 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Eli Lilly’s $3.5 Billion Manufacturing Campus Advances in Upper Macungie, Pennsylvania

A planned $3.5 billion pharmaceutical manufacturing campus in Upper...

Overcoming Resistance-Associated Substitutions (RASs) to Direct-Acting Antivirals

Alt tag: Scientific illustration of Hepatitis C virus interacting...

Genentech Completes Structural Framework at New NC Manufacturing Facility

Genentech raised the final beam of its new Holly...

Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351

Japan-based Chugai Pharmaceutical has entered into an exclusive license...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »